Structure, activity and function of the lysine methyltransferase SETD5.

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• SET domain-containing 5 (SETD5) is a protein lysine methyltransferase.
• SETD5 methylates histone H3 on lysine 36 (H3K36), impacting transcription, euchromatin formation, and RNA processing.
• SETD5 mutations are linked to neurodevelopmental disorders and cancer, often resulting in hyperactivity.

Purpose of the Study:

• To provide an updated overview of SETD5's enzymatic activity and substrate specificity.
• To discuss the biological importance and molecular/cellular impact of SETD5 in health and disease.
• To explore potential therapeutic strategies targeting SETD5 dysregulation.

Main Methods:

• Literature review and synthesis of existing research on SETD5.
• Analysis of biochemical mechanisms underlying SETD5 regulation and function.
• Discussion of clinical implications and therapeutic avenues.

Main Results:

• SETD5 enzymatic activity and substrate specificity are crucial for its biological roles.
• Dysregulation of SETD5, particularly hyperactivity, contributes to disease pathogenesis.
• Understanding SETD5 regulation offers potential therapeutic targets.

Conclusions:

• SETD5 plays a critical role in gene regulation and cellular processes.
• Aberrant SETD5 function is implicated in human diseases.
• Further research into SETD5 mechanisms may yield novel therapeutic interventions.